We note that BGI Group and subsidiaries, together with more than 180 other Chinese companies across multiple sectors, have been included on the latest U.S. Department of War list of “Chinese military companies” operating directly or indirectly in the United States. This list is updated annually in accordance with Section 1260H of the National Defense Authorization Act for Fiscal Year 2021.

BGI Group and its subsidiaries are accused of being “a military-civil fusion contributor to the Chinese defense industrial base.”

We strongly refute this accusation. Statements alleging BGI Group is controlled by the Chinese government or military are false. BGI is privately owned, in compliance with applicable laws and regulations and with research results shared with the world through numerous papers published in the most renowned scientific journals.

As a leading global life sciences organization, BGI Group works with partners around the world, including in the U.S., to make vital contributions to world health research, medical breakthroughs, and disease fighting. We are committed to enhancing health outcomes worldwide. This was, is, and always will be the company's mission.